Among these, ASCT2, GLS1, LAT1, SLC7A11, SLC3A2, and SHMT2 are key regulators of amino acid metabolism and have been implicated in tumour progression, therapy resistance, and immune evasion. The gene discussed is SLC7A11; the disease is neoplasm.